![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, November 07, 2005 7:37:56 AM
Logistical procedural efficiency in analysis for DNAG's specialized protocol cannot overcome the fact that the general forensics market is not generating significant revenues for certified companies, such as ORCH, which is head and shoulders above DNAG in this field of technology. Check out the recent news reports regarding ORCH's problems.
So you are saying Frudakis was trying to "keep people off the trail" of his valuable revenue generating forensics technology, even though all his patent applications have been fully published for all the public to see? Please try again! LOL!
JMHO from the facts.
dr f
FEATURED Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM